Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 3I.2I2.3Na |
| Molecular Weight | 957.3006 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[Na+].[I-].[I-].[I-].II.II
InChI
InChIKey=KSWLCNBBICEDRH-UHFFFAOYSA-K
InChI=1S/2I2.3HI.3Na/c2*1-2;;;;;;/h;;3*1H;;;/q;;;;;3*+1/p-3
| Molecular Formula | I2 |
| Molecular Weight | 253.8089 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.9898 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | HI |
| Molecular Weight | 127.9124 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Tetraglycine hydroperiodide is an iodine-containing chemical, used for water purification. Tetraglycine hydroperiodide is marketed in tablets; each tablet effectively disinfects 1 liter of clear water or 0.5 liter of tainted water by releasing approximately 8 mg free iodine. It requires approximately 30 minutes to inactivate target microorganisms and make water bacteriologically suitable for drinking. To remove iodine taste, a vitamin C pill is added to the kit.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Subfulminant hepatitis requiring liver transplantation after benzarone administration. | 1994 Jun |
|
| Thyroid adaptation to chronic tetraglycine hydroperiodide water purification tablet use. | 1995 Jan |
|
| Thyrotropin-secreting pituitary adenoma responsive to bromocriptine therapy. | 1999 Sep-Oct |
|
| [Effect of high-iodine intake on MBP mRNA expression in cerebrum of filial mice and selenium intervention]. | 2005 Jul |
|
| Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment Evidence that I2 prevents cancer promotion. | 2005 May 31 |
|
| Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma. | 2005 Oct |
|
| Effect of selenium supplementation on activity and mRNA expression of type 1 deiodinase in mice with excessive iodine intake. | 2006 Aug |
|
| Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via Claudin-5 modulation. | 2006 Aug 1 |
|
| The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland. | 2006 Mar |
|
| Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment. | 2007 Mar |
|
| Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC). | 2007 Nov |
|
| I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. | 2011 Jul |
|
| Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. | 2013 Jan |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:03:30 GMT 2023
by
admin
on
Sat Dec 16 05:03:30 GMT 2023
|
| Record UNII |
2A046O8RHQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
76965669
Created by
admin on Sat Dec 16 05:03:30 GMT 2023 , Edited by admin on Sat Dec 16 05:03:30 GMT 2023
|
PRIMARY | |||
|
2A046O8RHQ
Created by
admin on Sat Dec 16 05:03:30 GMT 2023 , Edited by admin on Sat Dec 16 05:03:30 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
